Lindsay Gnade
Medical · Orland Park, ILNPI 1295923936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $527 and has fallen 93.8% since, to $33 in 2025.
Across 82 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$266
- Lilly USA, LLC$194
- AbbVie$160
- Abbott$115
- Boehringer Ingelheim$110
- Amgen$94
- plus $507 from 15 others
What the payments were for
- Food & beverage$1,446100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $266 |
| Lilly USA, LLC | 11 | $194 |
| AbbVie | 9 | $160 |
| Abbott | 5 | $115 |
| Boehringer Ingelheim | 5 | $110 |
| Amgen | 7 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| GSK | 4 | $66 |
| Bayer | 3 | $54 |
| AstraZeneca | 4 | $50 |
| Currax Pharmaceuticals LLC | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $37 |
| Organon | 2 | $33 |
| Johnson & Johnson | 1 | $27 |
| Sobi, Inc | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$1,446 in reported general payments places this provider in the 70th percentile of 449 medical providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 49 | $537 |
| Levothyroxine Sodium | 49 | $502 |
| Losartan Potassium | 47 | $427 |
| Omeprazole | 24 | $325 |
| Amlodipine Besylate | 26 | $207 |
| Metoprolol Succinate | 17 | $188 |
| Sertraline Hcl | 20 | $187 |
| Rosuvastatin Calcium | 18 | $184 |
| Escitalopram Oxalate | 11 | $153 |
| Metformin Hcl ErMetformin Hcl | 13 | $119 |
| Hydrochlorothiazide | 16 | $112 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $65 |
| Simvastatin | 14 | $55 |
| Alprazolam | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other medical in Orland Park
- Luca JuuhlOrland Park$8K
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
- Megan GriggsSpringfield$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.